Develops research models for drug discovery and development.
Jun 2026Revenue $4.00B/yrExpenses $3.91B/yr
Expected to fall below break-even Feb 2029
Figures by year
Is Charles River Laboratories International still profitable?
Yes. In the 12 months to Jun 2026, revenue was $4.00B and expenses $3.91B. Its expenses are growing faster than its revenue, and the trends are projected to cross in Feb 2029.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.02B | $3.99B | $25.2M |
| Dec 2024 | $4.05B | $3.82B | $227M |
| Dec 2023 | $4.13B | $3.51B | $617M |
| Dec 2022 | $3.98B | $3.33B | $651M |
| Dec 2021 | $3.54B | $2.95B | $590M |
| Dec 2020 | $2.92B | $2.49B | $433M |
| Dec 2019 | $2.62B | $2.27B | $351M |
| Dec 2018 | $2.27B | $1.93B | $331M |
| Dec 2017 | $1.86B | $1.57B | $288M |
| Dec 2016 | $1.68B | $1.44B | $238M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.